Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease.
作者信息
Jung Han Na, Jung Chang Hee
机构信息
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Asan Diabetes Center, Asan Medical Center, Seoul, Korea.
出版信息
Diabetes Metab J. 2023 Mar;47(2):198-200. doi: 10.4093/dmj.2023.0038. Epub 2023 Mar 15.
Abstract
摘要
相似文献
1
Comparing the Mortality Risk between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease.比较代谢功能障碍相关脂肪性肝病与非酒精性脂肪性肝病之间的死亡风险。
Diabetes Metab J. 2023 Mar;47(2):198-200. doi: 10.4093/dmj.2023.0038. Epub 2023 Mar 15.
2
Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis.心血管危险因素和代谢综合征与非酒精性和酒精性脂肪性肝病的关系：一项回顾性分析。
BMC Endocr Disord. 2021 May 1;21(1):91. doi: 10.1186/s12902-021-00758-x.
3
Impact of Helicobacter pylori-linked metabolic syndrome on non-alcoholic fatty liver disease and its connected atrial fibrillation risk.幽门螺杆菌相关代谢综合征对非酒精性脂肪性肝病及其相关房颤风险的影响。
Liver Int. 2020 Aug;40(8):2036-2037. doi: 10.1111/liv.14488. Epub 2020 Jun 7.
4
Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19.致编辑的信：肥胖、糖尿病、非酒精性脂肪性肝病和代谢功能障碍相关脂肪性肝病是与新冠病毒疾病严重程度及血栓形成相关的促炎高凝状态。
Metabolism. 2021 Feb;115:154437. doi: 10.1016/j.metabol.2020.154437. Epub 2020 Nov 19.
5
Metabolic syndrome, non-alcoholic fatty liver disease and hepatocarcinoma.代谢综合征、非酒精性脂肪肝和肝癌。
Rev Esp Enferm Dig. 2020 Feb;112(2):133-138. doi: 10.17235/reed.2020.6640/2019.
6
The relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non-alcoholic fatty liver disease.中国同时患有肥胖症和非酒精性脂肪肝的青少年中，胰腺脂肪变性与代谢综合征和胰岛素抵抗风险的关系。
Pediatr Obes. 2020 Sep;15(9):e12653. doi: 10.1111/ijpo.12653. Epub 2020 Apr 29.
7
Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk.非酒精性脂肪性肝病、胰岛素抵抗、代谢综合征及其与血管风险的关系。
Metabolism. 2021 Jun;119:154770. doi: 10.1016/j.metabol.2021.154770. Epub 2021 Apr 14.
8
Letter to the Editor: Nonalcoholic Fatty Liver Disease Without Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome.致编辑的信：无代谢相关脂肪性肝病及代谢综合征的非酒精性脂肪性肝病
Clin Gastroenterol Hepatol. 2023 Aug;21(9):2435. doi: 10.1016/j.cgh.2022.10.034. Epub 2022 Nov 11.
9
Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy.
Ter Arkh. 2019 Mar 18;91(2):109-117. doi: 10.26442/00403660.2019.02.000122.
10
Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病中的心脏代谢紊乱。
Int J Mol Sci. 2019 May 6;20(9):2215. doi: 10.3390/ijms20092215.
本文引用的文献
1
Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study.代谢功能障碍相关脂肪性肝病与死亡率：一项基于人群的队列研究。
Diabetes Metab J. 2023 Mar;47(2):220-231. doi: 10.4093/dmj.2021.0327. Epub 2023 Jan 12.
2
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease.代谢功能障碍相关脂肪性肝病的流行病学、自然史及诊断：与非酒精性脂肪性肝病的比较性综述
Ther Adv Endocrinol Metab. 2022 Dec 10;13:20420188221139650. doi: 10.1177/20420188221139650. eCollection 2022.
3
Metabolic-associated Fatty Liver Disease: Time to integrate ground-breaking new terminology to our clinical practice?代谢相关脂肪性肝病：是时候将开创性的新术语融入我们的临床实践了吗？
Hepatol Forum. 2020 Sep 21;1(3):79-81. doi: 10.14744/hf.2020.2020.0024. eCollection 2020 Sep.
4
Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease.代谢功能障碍相关脂肪性肝病比非酒精性脂肪性肝病与更严重的肺功能损害相关。
J Clin Transl Hepatol. 2022 Apr 28;10(2):230-237. doi: 10.14218/JCTH.2021.00306. Epub 2022 Jan 4.
5
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.代谢相关脂肪性肝病（MAFLD）：一种超越肝脏的多系统疾病。
J Clin Transl Hepatol. 2022 Apr 28;10(2):329-338. doi: 10.14218/JCTH.2021.00178. Epub 2021 Oct 19.
6
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study.代谢相关脂肪性肝病与慢性肾脏病发病风险的关系：一项全国性队列研究。
Diabetes Metab. 2022 Jul;48(4):101344. doi: 10.1016/j.diabet.2022.101344. Epub 2022 Mar 25.
7
Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病成人患者结局的前瞻性研究。
N Engl J Med. 2021 Oct 21;385(17):1559-1569. doi: 10.1056/NEJMoa2029349.
8
Metabolic associated fatty liver disease is a risk factor for chronic kidney disease.代谢相关脂肪性肝病是慢性肾脏病的一个危险因素。
J Diabetes Investig. 2022 Feb;13(2):308-316. doi: 10.1111/jdi.13678. Epub 2021 Oct 12.
9
Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States.代谢相关脂肪性肝病与全因死亡率增加相关在美国。
J Hepatol. 2021 Dec;75(6):1284-1291. doi: 10.1016/j.jhep.2021.07.035. Epub 2021 Aug 8.
10
NAFLD or MAFLD: Which Has Closer Association With All-Cause and Cause-Specific Mortality?-Results From NHANES III.非酒精性脂肪性肝病（NAFLD）还是代谢功能障碍相关脂肪性肝病（MAFLD）：哪种与全因死亡率和特定病因死亡率的关联更紧密？——来自美国国家健康和营养检查调查（NHANES）III的结果
Front Med (Lausanne). 2021 Jul 1;8:693507. doi: 10.3389/fmed.2021.693507. eCollection 2021.
Zotero 插件